Prostatype Genomics AB

At a glance

Most recent filing on September 17, 2026 — an option exercise by Anders Lundberg on Sep 16, 2026.

We hold 5 visible filings, going back to September 15, 2026.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

All 5 shown

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Anders Lundberg Board member
1,287,500 sharesOption exercise
TradedSep 16, 2026FiledSep 17, 2026
Jörgen Dahlström Board member
668,000 sharesOption exercise
TradedSep 15, 2026FiledSep 16, 2026
Liljeblad & Co Aktiebolag Closely associated: Chair of the board
1,437,500 sharesOption exercise
TradedSep 15, 2026FiledSep 16, 2026
Håkan Englund Board member
5,562,500 sharesOption exercise
TradedSep 15, 2026FiledSep 16, 2026
Carisus Consulting AB Closely associated: Chief financial officer
62,500 SEKOption exercise
TradedSep 15, 2026FiledSep 15, 2026